TNYA Tenaya Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNYA

Price (delayed)

$0.7847

Market cap

$170.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.46

Enterprise value

$99.51M

?
Relative Growth: Rel. Growth: 21
Relative Strength: Rel. Strength: 65
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 33
Highlights
The EPS has surged by 60% year-on-year and by 22% since the previous quarter
The debt has declined by 22% year-on-year and by 7% since the previous quarter
The quick ratio is down by 16% QoQ and by 13% YoY
TNYA's equity is down by 14% from the previous quarter and by 11% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of TNYA

TNYA stock price

How has the Tenaya Therapeutics stock price performed over time
Intraday
-0.14%
1 week
-1.78%
1 month
-0.67%
1 year
48.98%
YTD
10.29%
QTD
13.33%

Financial performance

How have Tenaya Therapeutics's revenue and profit performed over time
Revenue
$225,000
Gross profit
$225,000
Operating income
-$85.86M
Net income
-$83.01M
Gross margin
100%
Net margin
-36,891.1%
The net income is up by 22% year-on-year and by 8% since the previous quarter
The operating income has grown by 22% year-on-year and by 8% since the previous quarter

Price vs fundamentals

How does TNYA's price correlate with its fundamentals

Growth

What is Tenaya Therapeutics's growth rate over time

Valuation

What is Tenaya Therapeutics stock price valuation
P/E
N/A
P/B
1.6
P/S
756.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
442.26
The EPS has surged by 60% year-on-year and by 22% since the previous quarter
TNYA's equity is down by 14% from the previous quarter and by 11% YoY
TNYA's P/B is 7% above its 5-year quarterly average of 1.5

Efficiency

How efficient is Tenaya Therapeutics business performance
TNYA's ROIC has shrunk by 75% YoY and by 11% QoQ
Tenaya Therapeutics's return on equity has increased by 13% YoY and by 5% QoQ
The ROA has grown by 12% YoY and by 7% from the previous quarter

Dividends

What is TNYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNYA.

Financial health

How did Tenaya Therapeutics financials performed over time
TNYA's total liabilities is up by 22% since the previous quarter and by 18% year-on-year
The quick ratio is down by 16% QoQ and by 13% YoY
The debt is 90% smaller than the equity
The debt has declined by 22% year-on-year and by 7% since the previous quarter
TNYA's equity is down by 14% from the previous quarter and by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.